Moreover, both IL-4+ BTLA-positive and IL-4+ BTLA-negative fractions from CLL patients were found to be significantly decreased in comparison to corresponding T cells in HC (p = 0.0016 and p = 0.0286, respectively) (Table 2, Figure 3e,f). Here, BTLA is linked to B-cell chronic lymphocytic leukemia.